×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Pyxis Oncology Inc. (PYXS) NASDAQ

$4.20 0.37 (9.66%)

Market Cap: $244.16M

As of 03/27/24 04:00 PM EDT. Market closed.

(PYXS)

Pyxis Oncology Inc. (PYXS)
NASDAQ

$4.20
0.37 (9.66%)

Market Cap: $244.16M

As of 03/27/24 04:00 PM EDT. Market closed.

Add to Portfolio

pyxis oncology is developing antibody therapeutics to promote the body's immune response to cancer, based on new insights into the tumor ... read more

pyxis oncology is developing antibody therapeutics to promote the body's immune response to cancer, based on new insights into the tumor micro-environment. read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Full Time Employees
70
Address
.
PRICE CHART FOR PYXIS ONCOLOGY INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$3.85
Previous Close
$3.83
Days Range
$3.79 - $4.27
52 week range
$1.35 - $6.92
Volume
789,723
Avg. Volume (30 days)
776,428
Market Cap
$244.16M
Dividend Yield
-
P/E
-
Shares Outstanding
58,133,375
Open
$3.85
Previous Close
$3.83
Days Range
$3.79 - $4.27
52 week range
$1.35 - $6.92
Volume
789,723
Avg. Volume (30 days)
776,428
Market Cap
$244.16M
Dividend Yield
-
P/E
-
Shares Outstanding
58,133,375
FINANCIAL STATEMENTS FOR PYXIS ONCOLOGY INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR PYXIS ONCOLOGY INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Connealy Pamela AnnCFO and COONov 29, 2023 Option Exercise$1.4036,94951,729781,583Nov 30, 2023, 04:15 PM
Connealy Pamela AnnCFO and COOSep 28, 2023 Buy$1.878,00014,960818,532Sep 28, 2023, 04:32 PM
Wadhane JitendraChief Accounting OfficerSep 27, 2023 Buy$1.872,5004,675226,937Sep 27, 2023, 06:37 PM
Connealy Pamela AnnCFO and COOSep 27, 2023 Buy$1.856,42611,868810,532Sep 27, 2023, 06:36 PM
Wadhane JitendraChief Accounting OfficerSep 25, 2023 Buy$1.775,0008,850224,437Sep 25, 2023, 05:05 PM
Connealy Pamela AnnCFO and COOSep 25, 2023 Buy$1.6712,00020,044804,106Sep 25, 2023, 05:04 PM
Wadhane JitendraChief Accounting OfficerSep 22, 2023 Buy$1.742,5004,349219,437Sep 22, 2023, 07:35 PM
Connealy Pamela AnnCFO and COOSep 22, 2023 Buy$1.745,0008,695792,106Sep 22, 2023, 07:34 PM
Sullivan LaraPresident and CEOSep 18, 2023 Sale$2.108,54117,9362,403,882Sep 18, 2023, 07:03 PM
Sullivan LaraPresident and CEOSep 14, 2023 Sale$2.251002252,412,423Sep 18, 2023, 07:03 PM
Sullivan LaraPresident and CEOSep 13, 2023 Option Exercise$2.13184,742393,5002,412,523Sep 13, 2023, 08:16 PM
Sullivan LaraPresident and CEOSep 13, 2023 Sale$2.273,0006,8162,597,265Sep 13, 2023, 08:16 PM
Sullivan LaraPresident and CEOSep 12, 2023 Sale$2.254,91711,0712,600,265Sep 13, 2023, 08:16 PM
Sullivan LaraPresident and CEOSep 11, 2023 Sale$2.2720,00045,4142,605,182Sep 13, 2023, 08:16 PM
PFIZER INC10% OwnerMar 17, 2023 Buy$2.761,811,5944,999,9995,952,263Mar 23, 2023, 04:14 PM
PFIZER INC10% OwnerMar 17, 2023 Buy$2.761,811,5944,999,9995,952,263Mar 21, 2023, 06:07 PM
Chin MarkFormer DirectorApr 21, 2022 Sale$3.051,745,7615,324,5710Apr 25, 2022, 12:12 PM
Cline Darren SDirectorDec 08, 2021 Buy$9.3910,00093,88510,000Dec 09, 2021, 04:18 PM
Civik ThomasDirectorNov 18, 2021 Buy$12.7415,700200,01815,700Nov 19, 2021, 01:21 PM
Chin MarkDirectorOct 13, 2021 Buy$16.00312,5005,000,0001,745,761Oct 15, 2021, 05:37 PM
Cormorant Asset Management, LPFormer 10% OwnerOct 13, 2021 Buy$16.00450,0007,200,0001,118,854Oct 15, 2021, 04:12 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Connealy Pamela AnnCFO and COO11/29/202351,729
Connealy Pamela AnnCFO and COO09/28/202314,960
Wadhane JitendraChief Accounting Officer09/27/20234,675
Connealy Pamela AnnCFO and COO09/27/202311,868
Wadhane JitendraChief Accounting Officer09/25/20238,850
Connealy Pamela AnnCFO and COO09/25/202320,044
Wadhane JitendraChief Accounting Officer09/22/20234,349
Connealy Pamela AnnCFO and COO09/22/20238,695
Sullivan LaraPresident and CEO09/18/202317,936
Sullivan LaraPresident and CEO09/14/2023225
Sullivan LaraPresident and CEO09/13/2023393,500
Sullivan LaraPresident and CEO09/13/20236,816
Sullivan LaraPresident and CEO09/12/202311,071
Sullivan LaraPresident and CEO09/11/202345,414
PFIZER INC10% Owner03/17/20234,999,999
PFIZER INC10% Owner03/17/20234,999,999
Chin MarkFormer Director04/21/20225,324,571
Cline Darren SDirector12/08/202193,885
Civik ThomasDirector11/18/2021200,018
Chin MarkDirector10/13/20215,000,000
Cormorant Asset Management, LPFormer 10% Owner10/13/20217,200,000
Load More Insider Transactions
FUNDS WITH A POSITION IN PYXIS ONCOLOGY INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
HHLR ADVISORS, LTD.382,6060.01%No changeOther
RENAISSANCE TECHNOLOGIES LLC364,1500.00101%68.39%Other
BLACKROCK INC.310,5980.00001%3.01%Other
GEODE CAPITAL MANAGEMENT, LLC308,2410.00006%6.92%Other
CHANGE IN SHARES OUTSTANDING FOR PYXIS ONCOLOGY INC
STOCK BUYBACKS FOR PYXIS ONCOLOGY INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
7.62%
1Q
12/31/2023
06/30/2023
15.87%
2Q
12/31/2023
03/31/2023
25.82%
3Q
12/31/2023
12/31/2022
27.82%
4Q
12/31/2023
09/30/2022
36.60%
5Q
12/31/2023
06/30/2022
37.07%
6Q
12/31/2023
03/31/2022
37.64%
7Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
7.62%
1Q
06/30/2023
15.87%
2Q
03/31/2023
25.82%
3Q
12/31/2022
27.82%
4Q
09/30/2022
36.60%
5Q
06/30/2022
37.07%
6Q
03/31/2022
37.64%
7Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR PYXIS ONCOLOGY INC
LOADING...